Search results for "EROI"

showing 10 items of 1497 documents

INHIBITION OF CELLULAR GROWTH AND STEROID 11β-HYDROXYLATION INRAS-TRANSFORMED ADRENOCORTICAL CELLS BY THE FUNGAL TOXINS BETICOLINS

1996

Abstract The proliferation of GM16 and 4CDTras-transformed newborn rat adrenocortical (RTAC) cells and Y1 mouse adrenal tumor cells was inhibited by beticolins, the fungal toxins extracted fromCercospora beticola, at submicromolar concentrations in a dose-dependent manner. Inhibitory concentrations for half the maximum inhibition were 150, 75 and 25 n M for beticolin-1 and 230, 150 and 50 n M for beticolin-2 in GM16, 4CDT and Y1 cells respectively. Beticolins strongly inhibited the production of 11β-hydroxysteroids on the second and third days of treatment in a dose-dependent manner between 0.1 and 1 μ M . Beticolins were shown by confocal microscopy to be localized in cytoplasmic organelle…

medicine.medical_treatmentAdrenal Gland NeoplasmsBiologyTransfectionHeterocyclic Compounds 4 or More RingsSteroidlaw.inventionHydroxylationMiceStructure-Activity Relationshipchemistry.chemical_compoundConfocal microscopylawOrganelleTumor Cells CulturedmedicineAnimalsCells CulturedHydroxysteroidsMicroscopy ConfocalDose-Response Relationship DrugCell growthCell BiologyGeneral MedicineMycotoxinsGrowth InhibitorsNeoplasm ProteinsRatsCell Transformation NeoplasticGenes rasAnimals NewbornchemistryBiochemistryCytoplasmAdrenal CortexSteroid 11-beta-HydroxylaseSignal transductionGrowth inhibitionCell DivisionCell Biology International
researchProduct

Synthesis of biotin-labelled dexamethasone derivatives. Novel hormone-affinity probes.

1983

A new, general methodology for 'sandwich' affinity chromatography of steroid hormone receptors is proposed, the part purification of the human spleen tumor glucocorticoid receptor is quoted as an illustration. 9-Fluoro-16 alpha-methyl-11 beta, 17-dihydroxy-1,4-androstadiene-3-one-17 beta-carboxylic acid was coupled to biotin using pentamethylenediamine (BioDex 1) as a spacer. The bifunctional derivative binds to glucocorticoid receptors and avidin-Sepharose and efficiently protects the glucocorticoid receptor against inactivation when previously added during homogenisation. We have standardized the capacity and optimum conditions for elution of receptor-BioDex-1 complexes which are bound to…

medicine.medical_treatmentBiotinBiochemistryBinding CompetitiveChromatography AffinityDexamethasoneSteroidchemistry.chemical_compoundGlucocorticoid receptorCytosolReceptors GlucocorticoidAffinity chromatographyBiotinCadaverinemedicineHumansBinding siteReceptorPolyacrylamide gel electrophoresisChromatographyBinding SitesChemistrySplenic NeoplasmsAffinity LabelsSteroid hormoneBiochemistryElectrophoresis Polyacrylamide GelEuropean journal of biochemistry
researchProduct

Instability of misoprostol tablets stored outside the blister: a potential serious concern for clinical outcome in medical abortion.

2014

IntroductionMisoprostol (Cytotec) is recognised to be effective for many gynaecological indications including termination of pregnancy, management of miscarriage and postpartum haemorrhage. Although not licensed for such indications, it has been used for these purposes by millions of women throughout the world. Misoprostol tablets are most often packaged as multiple tablets within an aluminium strip, each within an individual alveolus. When an alveolus is opened, tablets will be exposed to atmospheric conditions.ObjectiveTo compare the pharmaco technical characteristics (weight, friability), water content, misoprostol content and decomposition product content (type A misoprostol, type B mis…

medicine.medical_treatmentGlobal HealthMiscarriageDrug StabilityPregnancyMedicine and Health SciencesMedicinePublic and Occupational HealthClinical efficacyTermination of PregnancyMisoprostolMultidisciplinaryDrug InformationQRObstetrics and GynecologyEstabilidade de Medicamentosrespiratory systemMedical abortionObstetric ProceduresAnesthesiaMedicineFemaleMisoprostolTabletsResearch Articlemedicine.drugmedicine.medical_specialtyDrug StorageScienceSurgical and Invasive Medical ProceduresFriabilityAbortivos não EsteroidesHumansHealth Care QualityPharmacologyAbortifacient Agents NonsteroidalHealth Care PolicyHealth professionalsbusiness.industryAbortion InducedHumiditySmall sampleCommunication in Health Caremedicine.diseasePostpartum haemorrhageSurgeryHealth CareMedical EducationWomen's HealthAborto InduzidoClinical MedicinebusinessMedical HumanitiesPLoS ONE
researchProduct

A pyrroloquinazoline derivative with anti-inflammatory and analgesic activity by dual inhibition of cyclo-oxygenase-2 and 5-lipoxygenase

2002

Abstract In a previous study, we reported a new pyrroloquinazoline derivative, 3-(4′-acetoxy-3′,5′-dimethoxy)benzylidene-1,2-dihydropyrrolo[2,1- b ]quinazoline-9-one (PQ), which inhibited human purified 5-lipoxygenase activity and prostaglandin E 2 release in lipopolysaccharide-stimulated RAW 264.7 cells. In the present work, we show that PQ inhibits cyclo-oxygenase-2 activity in intact cell assays (human monocytes) and purified enzyme preparations (ovine isoenzymes) without affecting cyclo-oxygenase-1 activity. This behaviour was confirmed in vivo by using the zymosan-injected mouse air pouch model, where PQ caused a marked reduction in cell migration and leukotriene B 4 levels at 4 h, as …

medicine.medical_treatmentPharmacologyMonocytesMicechemistry.chemical_compoundIn vivomedicineAnimalsEdemaHumansCyclooxygenase InhibitorsPyrrolesLipoxygenase InhibitorsEnzyme InhibitorsProstaglandin E2Pain MeasurementPharmacologyAnalgesicsArachidonate 5-LipoxygenaseSheepCyclooxygenase 2 InhibitorsDose-Response Relationship DrugbiologyChemistryAnti-Inflammatory Agents Non-SteroidalZymosanMembrane ProteinsBiological activityIsoenzymesBiochemistryMechanism of actionCyclooxygenase 2Prostaglandin-Endoperoxide SynthasesEnzyme inhibitorArachidonate 5-lipoxygenaseQuinazolinesQuinolinesbiology.proteinFemalemedicine.symptomProstaglandin Emedicine.drug
researchProduct

Cytotoxicity of natural products and derivatives toward MCF-7 cell monolayers and cancer stem-like mammospheres

2015

Abstract Although cancer stem-like cells (CSCs) are rare, they can enter a non-proliferative or dormant state and resist therapy. Furthermore, quiescent CSCs are responsible for metastases that can appear after curative surgical treatment of a primary tumor. Because of drug resistance of CSCs, the development of novel therapies is urgently required that specifically target CSCs. Purpose The aim of the present study was to investigate the potential of a panel of natural products and derivatives to inhibit CSC-enriched mammospheres of MCF-7 breast cancer cells. Methods CD44high/CD24low cells were identified by flow cytometry and maintained as mammospheres. As a control, we used two clinically…

medicine.medical_treatmentPhytochemicalsCellArtesunatePharmaceutical ScienceAntineoplastic AgentsBiologyPharmacologyFlow cytometrySpheroids CellularStilbenesDrug DiscoverymedicineHumansCytotoxicityPharmacologyChemotherapymedicine.diagnostic_testCancermedicine.diseasePrimary tumorArtemisininsSalicylatesmedicine.anatomical_structureComplementary and alternative medicineDocetaxelMCF-7MCF-7 CellsNeoplastic Stem CellsMolecular MedicineNaphthoquinonesmedicine.drugPhytomedicine
researchProduct

Cancer-Initiating Cells from Colorectal Cancer Patients Escape from T Cell-Mediated Immunosurveillance In Vitro through Membrane-Bound IL-4

2014

Abstract Cancer-initiating cells (CICs) that are responsible for tumor initiation, propagation, and resistance to standard therapies have been isolated from human solid tumors, including colorectal cancer (CRC). The aim of this study was to obtain an immunological profile of CRC-derived CICs and to identify CIC-associated target molecules for T cell immunotherapy. We have isolated cells with CIC properties along with their putative non-CIC autologous counterparts from human primary CRC tissues. These CICs have been shown to display “tumor-initiating/stemness” properties, including the expression of CIC-associated markers (e.g., CD44, CD24, ALDH-1, EpCAM, Lgr5), multipotency, and tumorigenic…

medicine.medical_treatmentT cellT-LymphocytesImmunologyTumor initiationCell CommunicationLymphocyte ActivationArticleImmune systemAntigenAntigens NeoplasmCell Line TumorSpheroids CellularmedicineTumor Cells CulturedImmunology and AllergyHumansImmunologic SurveillanceInterleukin 4Settore MED/04 - Patologia GeneralebiologyCD44Cell MembraneImmunotherapyImmunosurveillancemedicine.anatomical_structureImmunologybiology.proteinNeoplastic Stem CellsTumor EscapeInterleukin-4Colorectal NeoplasmsIL-4 Cancer-initiating cells (CICs)
researchProduct

Amplicon-based high-throughput pooled sequencing identifies mutations in CYP7B1 and SPG7 in sporadic spastic paraplegia patients

2011

Hereditary spastic paraplegia (HSP) is a neurodegenerative disorder defined clinically by progressive lower limb spasticity and weakness. HSP is a genetically highly heterogeneous condition with at least 46 gene loci identified so far, involving X-linked, autosomal recessive (AR) and autosomal dominant inheritance. For correct diagnosis, molecular testing is essential because clinical parameters by themselves are not reliable to differentiate HSP forms. The purpose of this study was to establish amplicon-based high-throughput genotyping for AR-HSP. A sample of 187 index cases with apparently sporadic or recessive spastic paraplegia were analyzed by applying an array-based amplification stra…

methods [High-Throughput Nucleotide Sequencing]GenotypeHereditary spastic paraplegiaDNA Mutational AnalysisMolecular Sequence DataSPG7 protein humanCytochrome P450 Family 7diagnosis [Paraplegia]Biologymedicine.disease_causegenetics [Paraplegia]Cohort Studiesgenetics [Metalloendopeptidases]03 medical and health sciences0302 clinical medicineGenetic variationGenotypeGeneticsmedicineHumansddc:610Genetic TestingGenotypingGenetics (clinical)CYP7B1 protein human030304 developmental biologyGenetic testingParaplegiaGenetics0303 health sciencesMutationBase SequenceParapleginmedicine.diagnostic_testgenetics [Steroid Hydroxylases]Genetic VariationHigh-Throughput Nucleotide SequencingMetalloendopeptidasesmethods [DNA Mutational Analysis]Ampliconmedicine.diseasegenetics [Genetic Variation]3. Good healthMutationSteroid HydroxylasesATPases Associated with Diverse Cellular Activities030217 neurology & neurosurgeryClinical Genetics
researchProduct

Johtoryhmän ominaisuuksien vaikutus suomalaisten pörssiyritysten suoritukseen

2013

Tutkielmassa selvitettiin johtoryhmien vaikutusta yrityksen suoritukseen. Teoreettinen näkökulma perustui organizational demography- ja upper echelons -teorioihin, joiden mukaan johtoryhmän ominaisuudet ryhmänä ovat seurausta jäsenten ominaisuuksista, ja nämä ominaisuudet heijastuvat strategisiin valintoihin ja suoritukseen. Päätavoite oli selvittää vaikuttavatko johtoryhmän ominaisuudet yrityksen suoritukseen. Lisäksi selvitettiin onko johtoryhmän monimuotoisuudella merkitystä suoritukseen ja muuttuuko vaikutus johtoryhmän toimikauden pituuden kasvaessa. Tutkimuskohteina olivat NASDAQ OMX Helsinki -pörssissä lokakuussa 2012 no-teeratut yritykset. Tiedot kerättiin vuoden 2011 johtoryhmästä …

moderoitu regressioanalyysisuoritusmonimuotoisuuspörssiyhtiötJohtoryhmäjohtoryhmät
researchProduct

Decreased serum levels of sex steroids associated with osteoporosis in a group of Romanian male patients

2016

Abstract Introduction. With age, sex hormone deficiency leads to reduced bone mineral density (BMD) in men. The aim of our research is to analyze the role of serum sex steroids in assessing BMD in the men included in this study. Materials and methods. This cross-sectional study included 146 men aged 65-85 years old with osteopenia or osteoporosis (study group) and 121 men with normal BMD (control group). Serum levels of total testosterone (Tt) and free testosterone (Tf) were measured by immunoassay, and estradiol (E2) levels were measured by the immunoenzymatic method. Femoral neck and lumbar spine BMD was examined by dual-energy X-ray absorptiometry. Results. Tf and E2 deficiency was signi…

musculoskeletal diseasesGynecologymedicine.medical_specialtybusiness.industrymusculoskeletal neural and ocular physiologyOsteoporosisRmenPhysiology030209 endocrinology & metabolismmusculoskeletal systemmedicine.disease03 medical and health sciences0302 clinical medicineMale patientHuman biologyMedicineMedicinesex steroids030212 general & internal medicinebone mineral densitybusinessRevista Romana de Medicina de Laborator
researchProduct

Estrogen metabolism modulates bone density in men.

2007

Estrogen is a critical hormone for bone homeostasis in men, but no information is available on the role of estrogen metabolism among men. The aim of this study was to evaluate the effect of estrogen hydroxylation on male bone mineral density (BMD). Participants consisted of 61 healthy Caucasian males (mean age 66.6 +/- 1.0 years). Urinary estrogen metabolites were measured by enzyme-linked immunosorbent assay, serum estradiol by ultrasensitive radioimmunoassay, sex hormone binding globulin by radioimmunoassay, and BMD of the lumbar spine and the proximal femur by dual-energy X-ray absorptiometry. Active estrogen metabolites, 16alpha-hydroxyestrone (16alphaOHE(1)) and estriol (E(3)), positiv…

musculoskeletal diseasesMalemedicine.medical_specialtyBone densitymedicine.drug_classEndocrinology Diabetes and MetabolismMotor ActivityHydroxylationArticleBody Mass IndexEndocrinologySex hormone-binding globulinBone DensityInternal medicinemedicineHumansOrthopedics and Sports MedicineFemoral neckAgedBone mineralAged 80 and overbiologyChemistryEstriolEstriolRadioimmunoassayEstrogensMiddle Agedmusculoskeletal systemEndocrinologymedicine.anatomical_structureCross-Sectional StudiesSteroid 16-alpha-HydroxylaseEstrogenbiology.proteinBody mass indexCalcified tissue international
researchProduct